It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study examined the latent structure of the broad range of complex neuropsychiatric morbidities occurring 1 year after COVID-19 infection. As part of the CU-COVID19 study, 248 (response rate=39.3%) of 631 adults hospitalized for COVID-19 infection in Hong Kong completed an online survey between March-2021 and January-2022. Disorder prevalence was compared against a random non-infected household sample (n=1834). 248 surveys were received on average 321 days post-infection (Mean age: 48.9, 54% female, moderate/severe/critical infection: 58.2%). 32.4% were screened to have at least one mental disorder, 78.7% of whom had concurrent fatigue/subjective cognitive impairment (SCI). Only PTSD (19.1%) was significantly more common than control (14%, p=0.047). Latent profile analysis classified individuals into P1 (12·4%)-no current neuropsychiatric morbidities, P2 (23.1%)-SCI/fatigue, P3 (45.2%)-anxiety/PTSD, P4 (19.3%)-depression. SCI and fatigue pervaded in all profiles (P2-4) with neuropsychiatric morbidities one-year post-infection. PTSD, anxiety and depressive symptoms were most important in differentiating P2-4. Past mental health and P4 independently predicted functional impairment. Neuropsychiatric morbidity was associated with past mental health, reduced resilience, financial problems, but not COVID-19 severity. Their confluence with depressive and anxiety symptoms predicted impairment and are associated with psychological and environmental factors.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The Chinese University of Hong Kong, Department of Psychiatry, Faculty of Medicine, Hong Kong, Hong Kong (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482)
2 The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Hong Kong, Hong Kong (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482)
3 Vrije Universiteit Amsterdam, Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227); Babeș-Bolyai University, International Institute for Psychotherapy, Cluj-Napoca, Romania (GRID:grid.7399.4) (ISNI:0000 0004 1937 1397)
4 Universitat Pompeu Fabra, CIBERESP, Health Services Research group, IMIM-Institut Hospital Mar d’Investigacions Mèdiques, Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676)
5 The Chinese University of Hong Kong, Department of Microbiology, Faculty of Medicine, Hong Kong, Hong Kong (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482)
6 The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Faculty of Medicine, Hong Kong, Hong Kong (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482)
7 Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
8 IMIM-Institut Hospital Mar d’Investigacions Mèdiques, CIBER Epidemiología y Salud Pública CIBERESP, Health Services Research group, Barcelona, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246)
9 Harvard Medical School, Department of Health Care Policy, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)